Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Cell-based tumor vaccine: Began Phase I trial

The Immune Response Corp. (IMNR), Carlsbad, Calif.
Product:

Read the full 87 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE